Lowering Inflammation Level by Lp-PLA2 Inhibitor (Darapladib) in Early Atherosclerosis Development: in vivo Rat Type 2 Diabetes Mellitus Model

Teuku H,Andri WT,Siswanto BB,Santoso A,Sukmawan R,Sargowo D, et al.Lowering Inflammation Level by Lp-PLA2 Inhibitor (Darapladib) in Early Atherosclerosis Development: in vivo Rat Type 2 Diabetes Mellitus Model. Journal of Cardiovascular Disease Research. 2016;7(4):148-53.

Source: Journal of Cardiovascular Disease Research - December 15, 2016 Category: Cardiology Authors: nandan Tags: Darapladib. inflammation Lipoprotein-associated phospholipase A2 oxidative stress Type 2 diabetes mellitus Source Type: research